Drug Type Interferons, Biosimilar |
Synonyms Xerfelan |
Target |
Action agonists, modulators |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Mexico (01 Aug 2012), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Multiple Sclerosis | Mexico | 01 Aug 2012 |